Skystar Bio-Pharmaceutical Co (FRA:GNJC) EBIT per Share : €1.38 (TTM As of Sep. 2014)

View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co EBIT per Share?

Skystar Bio-Pharmaceutical Co's EBIT per Share for the three months ended in Sep. 2014 was €0.60. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2014 was €1.38.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Skystar Bio-Pharmaceutical Co's EBIT per Share or its related term are showing as below:

FRA:GNJC's 3-Year EBIT Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.4
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Skystar Bio-Pharmaceutical Co's EBIT for the three months ended in Sep. 2014 was €4.56 Mil.

Skystar Bio-Pharmaceutical Co EBIT per Share Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co EBIT per Share Chart

Skystar Bio-Pharmaceutical Co Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

EBIT per Share

Get a 7-Day Free Trial

1.38

1.85

1.76

0.93

1.29

Skystar Bio-Pharmaceutical Co Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
EBIT per Share	Get a 7-Day Free Trial															0.46	0.28	0.14	0.35	0.60

Skystar Bio-Pharmaceutical Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Skystar Bio-Pharmaceutical Co's EBIT per Share for the fiscal year that ended in Dec. 2013 is calculated as

	EBIT per Share		(A: Dec. 2013 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	9.887	/	7.656
=	1.29

Skystar Bio-Pharmaceutical Co's EBIT per Share for the quarter that ended in Sep. 2014 is calculated as

	EBIT per Share		(Q: Sep. 2014 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	4.559	/	7.6048
=	0.60

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.38

Skystar Bio-Pharmaceutical Co (FRA:GNJC) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Skystar Bio-Pharmaceutical Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (FRA:GNJC) » Definitions » EBIT per Share

Traded in Other Exchanges

N/A

Address

No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN

Website

http://www.skystarbio-pharmaceutical.com

Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Headlines

No Headlines